A novel SLC20A2 nonsense variant and mechanistic studies of primary brain calcification
PLOS One · 2026
DOI: 10.1371/journal.pone.0346635 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Yi Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Sodium-Phosphate Cotransporter Proteins, Type III, Calcinosis, Codon, Nonsense, Brain Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science Fund for Distinguished Young Scholars of Hunan Province, Scientific Research Project of Hunan Provincial Health Commission.
Abstract (Originalsprache)
Primary brain calcification (PBC) is a rare neurodegenerative disease featured by bilateral brain calcifications and exhibiting high phenotypic and genetic heterogeneity. The clinical manifestations mainly include movement disorders, cognitive deficits, and neuropsychiatric symptoms. In this study, a novel heterozygous nonsense variant, c.1669C > T [p.(Gln557*)], in the solute carrier family 20 member 2 gene ( SLC20A2 ), encoding type III sodium-dependent inorganic phosphate transporter 2 (PiT2), was identified in a Han-Chinese family with PBC using whole exome sequencing and Sanger sequencing. Bioinformatics analysis predicted the variant’s deleterious effect. The cellular function impacts of the p.Gln557* variant and three other common PBC-related SLC20A2 variants, p.Ser113*, p.Ala585Thr, and p.Ser601Trp, were subsequently revealed. Subcellular localization analysis showed that the PiT2-Q557*, A585T, and S601W mutants mainly distributed in the plasma membrane and cytosol, whereas the PiT2-S113* mutant showed a diffuse distribution throughout the cells. All four investigated variants significantly impaired cellular inorganic phosphate transport activity. The protein mislocalization-inducing p.Ser113* variant likely causes haploinsufficiency, while the p.Gln557*, p.Ala585Thr, and p.Ser601Trp variants may lead to full or partial loss of function, or exert a dominant-negative effect. Cells expressing PiT2 mutants all exhibited inhibited proliferative and migratory activities, along with enhanced apoptosis. These SLC20A2 variants probably impair critical cellular functions, potentially providing an explanation for the neurological symptoms observed in PBC patients. These findings further broaden SLC20A2 variant spectrum and provide valuable mechanistic insights into the pathogenesis of SLC20A2 -associated PBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Research Center of Medical Experimental Technology, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Center for Experimental Medicine, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Neurology, the Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
- Department of Pathology, Hunan Aerospace Hospital, Changsha, Hunan, China.
- Disease Genome Research Center, Central South University, Changsha, Hunan, China.
ORCID-Profile: Hao Deng
Förderung
- National Natural Science Foundation of China
- Science Fund for Distinguished Young Scholars of Hunan Province
- Scientific Research Project of Hunan Provincial Health Commission
- Health Research Project of Hunan Provincial Health Commission
- Distinguished Professor of the Lotus Scholars Award Program of Hunan Province
- Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University
- Fundamental Research Funds for Central Universities of the Central South University
- Sublimation Scholars Project of Central South University
Zitieren
APA
Li, Y., Yuan, L., Chen, H., Zheng, W., Xu, H., Yang, Z., He, D., & Deng, H. (2026). A novel SLC20A2 nonsense variant and mechanistic studies of primary brain calcification. PLOS One. https://doi.org/10.1371/journal.pone.0346635
Vancouver
Li Y, Yuan L, Chen H, Zheng W, Xu H, Yang Z, et al. A novel SLC20A2 nonsense variant and mechanistic studies of primary brain calcification. PLOS One. 2026. doi:10.1371/journal.pone.0346635
BibTeX
@article{Li2026,
author = {Li, Yi and Yuan, Lamei and Chen, Han and Zheng, Wen and Xu, Hongbo and Yang, Zhijian and He, Dan and Deng, Hao},
title = {A novel SLC20A2 nonsense variant and mechanistic studies of primary brain calcification},
journal = {PLOS One},
year = {2026},
doi = {10.1371/journal.pone.0346635}
}
EUVIMED